To the attention of interested persons
Following finalisation of the assessment procedures, as well as of the notifications received from the National Health Insurance House on signing of cost-volume agreements, the National Agency for Medicines and Medical Devices has forwarded the List of International Non-proprietary Products proposed for inclusion into the reimbursement system to the Ministry of Health.
The proposals target the inclusion of 13 new INNs and amendment of 5 INNs in the List attached to Government Decision no. 720/2008.
Thus, the access to new therapeutic alternatives is ensured for:
– Oncology – for pulmonary neoplasm, prostate neoplasm, leukaemia, lymphoma, multiple myeloma
– Rare diseases – for Gaucher’s disease, immune thrombocytopenic purpura, Duchenne muscular dystrophy, hereditary angioedema
– Diabetes mellitus
– Pneumology – Chronic obstructive bronchopneumopathy (COBP) and pulmonary fibrosis.